Caroline Almeida
executiveFemale0.0Global Dominance: 0.00%
Caroline Almeida is the head of public affairs at Gilead Sciences, a biopharmaceutical company known for its innovative treatments for HIV and other diseases. Almeida has been involved in discussions regarding the pricing and accessibility of lenacapavir, emphasizing the company's commitment to providing a not-for-profit price for this critical medication in low- and middle-income countries.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Caroline Almeida is Gilead’s senior director for global affairs.
SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch – The Mail & GuardianMail & Guardian·
South Africa· 2025-12-01
South Africa· 2025-12-01
Caroline Almeida is Gilead’s head of public affairs discussing the pricing of lenacapavir.
SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag – The Mail & GuardianMail & Guardian·South Africa· 2025-07-16
South Africa· 2025-07-16
